Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 3 rd :
PRA Health Sciences, Inc. (PRAH): This contract research organization, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings improving 0.2% over the last 30 days.
PRA HEALTH SCI Price and Consensus
PRA HEALTH SCI Price and Consensus | PRA HEALTH SCI Quote
PRA Health Sciences has a price/earnings to growth ratio (PEG) of 0.99, compared with 1.24 for the industry. The company possesses a Growth Score of B.
OWENS CORNING Price and Consensus | OWENS CORNING Quote
Owens Corning has a PEG ratio of 1.16, compared with 1.36 for the industry. The company possesses a Growth Score of A.
MATADOR RESOURC Price and Consensus | MATADOR RESOURC Quote
Matador Resources has a PEG ratio of 1.17, compared with 1.37 for the industry. The company possesses a Growth Score of A.
VALIDUS HOLDING Price and Consensus | VALIDUS HOLDING Quote
Validus Holdings has a PEG ratio of 1.47, compared with 1.52 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
VALIDUS HOLDING (VR): Free Stock Analysis Report
PRA HEALTH SCI (PRAH): Free Stock Analysis Report
OWENS CORNING (OC): Free Stock Analysis Report
MATADOR RESOURC (MTDR): Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
